Published in Osteoporos Int on May 01, 1993
Digital X-ray radiogrammetry of hand or wrist radiographs can predict hip fracture risk--a study in 5,420 women and 2,837 men. Eur Radiol (2012) 1.49
Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int (2008) 1.45
Proximal humeral fracture as a risk factor for subsequent hip fractures. J Bone Joint Surg Am (2009) 1.28
Time trends of age-adjusted incidence rates of first hip fractures: a register-based study among older people in Viborg County, Denmark, 1987-1997. Osteoporos Int (2006) 1.19
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 1.07
Low-energy distal radius fractures in middle-aged and elderly women-seasonal variations, prevalence of osteoporosis, and associates with fractures. Osteoporos Int (2009) 1.06
The relation between bisphosphonate use and non-union of fractures of the humerus in older adults. Osteoporos Int (2008) 0.97
Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec. BMC Musculoskelet Disord (2005) 0.93
Bone mineral density and vitamin D status among African American children with forearm fractures. Pediatrics (2012) 0.91
[Do injuries of the upper extremity in geriatric patients end up in helplessness? A prospective study for the outcome of distal radius and proximal humerus fractures in individuals over 65]. Z Gerontol Geriatr (2006) 0.89
A population-based study on trend in incidence of distal radial fractures in adults in Taiwan in 2000-2007. Osteoporos Int (2010) 0.86
Premenopausal women with a distal radial fracture have deteriorated trabecular bone density and morphology compared with controls without a fracture. J Bone Joint Surg Am (2013) 0.86
Epidemiology of proximal humeral fractures in Austria between 1989 and 2008. Osteoporos Int (2013) 0.86
Patterns of Prescription Drug Use Before and After Fragility Fracture. JAMA Intern Med (2016) 0.81
Systematic review of the association between climate and hip fractures. Int J Biometeorol (2014) 0.81
A study of male patients with forearm fracture in Northern Ireland. Clin Rheumatol (2006) 0.81
Variation in the incidence of distal radius fractures in the U.S. elderly as related to slippery weather conditions. Plast Reconstr Surg (2014) 0.81
Inadequate management for secondary fracture prevention in patients with distal radius fracture by trauma surgeons. Osteoporos Int (2015) 0.81
Evaluation and treatment of osetoporotic distal radius fracture in the elderly patient. Curr Rev Musculoskelet Med (2013) 0.80
Combining clinical factors and quantitative ultrasound improves the detection of women both at low and high risk for hip fracture. Osteoporos Int (2007) 0.79
Prevalence and predictors of osteoporosis risk in orthopaedic patients. Clin Orthop Relat Res (2010) 0.78
Assessment of trabecular bone yield and post-yield behavior from high-resolution MRI-based nonlinear finite element analysis at the distal radius of premenopausal and postmenopausal women susceptible to osteoporosis. Acad Radiol (2013) 0.76
Trabecular bone loss at a distant skeletal site following noninvasive knee injury in mice. J Biomech Eng (2015) 0.76
A new fracture assessment approach coupling HR-pQCT imaging and fracture mechanics-based finite element modeling. J Biomech (2013) 0.76
Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study. J Bone Miner Res (2015) 0.76
A study of bone mineral density in women with forearm fracture in Northern Ireland. Osteoporos Int (2004) 0.75
Mortality after distal radial fractures in the Medicare population. J Hand Surg Eur Vol (2015) 0.75
Short-term relationship between hip fracture and weather conditions in two Spanish health areas with different climates. J Environ Public Health (2015) 0.75
Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre. Osteoporos Int (2015) 0.75
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int (2000) 4.85
Localization of the receptor-binding protein adhesin at the tip of the bacterial pilus. Nature (1987) 4.72
Genes of pyelonephritogenic E. coli required for digalactoside-specific agglutination of human cells. EMBO J (1984) 4.22
Effect of external hip protectors on hip fractures. Lancet (1993) 4.06
The PapG protein is the alpha-D-galactopyranosyl-(1----4)-beta-D-galactopyranose-binding adhesin of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (1987) 4.05
Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb Pathog (1990) 3.18
Gene products specifying adhesion of uropathogenic Escherichia coli are minor components of pili. Proc Natl Acad Sci U S A (1986) 2.58
Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1-4Gal-containing isoreceptors. EMBO J (1990) 2.31
Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension (1994) 2.28
Globoside-specific adhesins of uropathogenic Escherichia coli are encoded by similar trans-complementable gene clusters. J Bacteriol (1985) 2.23
Captured by art. Science (2001) 2.21
PapD, a periplasmic transport protein in P-pilus biogenesis. J Bacteriol (1989) 2.19
A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab (2012) 2.16
Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest (1980) 2.04
The role of second-look laparotomy in the long-term survival in ovarian cancer. Ann Oncol (1997) 1.97
[Improved quality of life with ginseng preparations? Positive effects in healthy working people]. Lakartidningen (1995) 1.93
The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains. Proc Natl Acad Sci U S A (1984) 1.82
Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet (1981) 1.81
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol (1994) 1.79
Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol (1995) 1.77
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer. J Clin Oncol (2000) 1.72
Transmission of scrapie by steel-surface-bound prions. Mol Med (2001) 1.63
Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine (1998) 1.63
Epidemiology of postmenopausal spinal and long bone fractures. A unifying approach to postmenopausal osteoporosis. Clin Orthop Relat Res (1982) 1.59
Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction. BMJ (1993) 1.58
Lymphocytopenia in a hospital population--what does it signify? Aust N Z J Med (1997) 1.57
Intravenous magnesium in acute myocardial infarction. Lancet (1986) 1.56
Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study. J Rheumatol (1988) 1.53
Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) (1979) 1.49
Dysplasia epiphysealis hemimelica (Trevor's disease) of the distal radius. Acta Orthop Belg (1998) 1.46
Determinants of vitamin D status in a general population of Danish adults. Bone (2011) 1.45
Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol (1995) 1.42
Clopidogrel and the risk of osteoporotic fractures: a nationwide cohort study. J Intern Med (2012) 1.41
Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes (1978) 1.41
Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex. Thromb Haemost (1995) 1.41
Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand (1981) 1.40
Genes determining adhesin formation in uropathogenic Escherichia coli. Curr Top Microbiol Immunol (1985) 1.40
Level versus inclined walking: ambulatory compensations in children with cerebral palsy under outdoor conditions. Pediatr Phys Ther (2014) 1.39
[Degenerative lumbar spondylolisthesis and spinal stenosis]. Ugeskr Laeger (1994) 1.39
Changing incidence and residual lifetime risk of common osteoporosis-related fractures. Osteoporos Int (1993) 1.39
An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta (1973) 1.37
Effect of puberty on rates of bone growth and mineralisation: with observations in male delayed puberty. Arch Dis Child (1979) 1.31
The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med (2006) 1.29
Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol. Lancet (1978) 1.29
Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med (1995) 1.28
Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol (Copenh) (1979) 1.28
Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium. Clin Endocrinol (Oxf) (1982) 1.24
Topoisomerase I inhibitors: topotecan and irenotecan. Cancer Treat Rev (1994) 1.22
Local recurrences in giant cell tumour of bone. Long-term follow up of 31 cases. Int Orthop (1996) 1.22
Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin-treated diabetic out-patients. Clin Chim Acta (1982) 1.19
Parathyroid hormone and bone healing. Calcif Tissue Int (2010) 1.18
Additional small acrocentric chromosome: two cases. J Ment Defic Res (1969) 1.17
Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol (Copenh) (1993) 1.12
Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells. Am J Physiol Endocrinol Metab (2003) 1.12
Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis. J Pathol (2000) 1.12
One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo. Clin Cardiol (1988) 1.11
New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased In vitro metabolic stability. J Med Chem (2000) 1.11
Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes (1978) 1.11
Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells. J Virol (2001) 1.10
Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes (1982) 1.09
Vitamin D and ischaemic heart disease. Horm Metab Res (1978) 1.09
Increased parathyroid hormone as a consequence of changed complex binding of plasma calcium in morbid obesity. Metabolism (1986) 1.08
Vitamin D metabolism in hypoparathyroidism. J Clin Endocrinol Metab (1980) 1.07
Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study. J Clin Oncol (1994) 1.06
Regional muscle tension and pain ("fibrositis"). Effect of massage on myoglobin in plasma. Scand J Rehabil Med (1983) 1.06
Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest (1982) 1.05
Mechanisms of resistance to imipenem in imipenem-resistant, ampicillin-sensitive Enterococcus faecium. APMIS (2001) 1.04
Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment. Arch Intern Med (1992) 1.03
Plasma 1,25-dihydroxyvitamin D levels in pregnancy and lactation. Acta Endocrinol (Copenh) (1979) 1.02
T cell vaccination in secondary progressive multiple sclerosis. J Neuroimmunol (2000) 1.02
Endocrine effects of lithium: II. 'Primary' hyperparathyroidism. Acta Endocrinol (Copenh) (1978) 1.02
Changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty. A 3-year follow-up of 25 knees. Acta Orthop Scand (1995) 1.02
Advanced epithelial ovarian cancer: 1998 consensus statements. Ann Oncol (1999) 1.02
Endocrine effects of lithium. I. Hypothyroidism, its prevalence in long-term treated patients. Acta Endocrinol (Copenh) (1978) 1.02
Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor. Ann Oncol (1993) 1.01
Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial. Ann Oncol (2012) 1.01
Influence of smoking on insulin requirement and metbolic status in diabetes mellitus. Diabetes Care (1980) 1.01
Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population. Scand J Clin Lab Invest (1979) 1.01
Incidence of sporting injury in New Zealand youths aged 6-15 years. Br J Sports Med (1998) 1.01
Changes in bone mineral density of the distal femur following uncemented total knee arthroplasty. J Arthroplasty (1995) 1.00